This webinar will describe convalescent plasma and its use in treatment for COVID-19 patients. Additionally, the experts will discuss how they established safety and serological testing, qualified COVID 19 convalescent plasma (CCP) donors, and are conducting clinical trials to determine CCP effectiveness in COVID-19 patients.
Key Learning Objectives:
After attending this webinar, you would be able to:
1. Describe how SARS-CoV-2 infects cells and how antibodies may prevent infection
2. Define convalescent plasma
3. Discuss the key aspects of ongoing COVID-19 convalescent plasma clinical trials